Aberrant transforming growth factor β (TGF-β) signaling is involved in the pathogenesis of BPH, resulting in stromal proliferation, epithelial-mesenchymal transition (EMT), transdifferentiation, and extracellular matrix production [15–18]. Here, TGFB1 is linked to benign prostatic hyperplasia.